drugset / Trial / NCT05719155

Pharmacokinetics and Safety/Tolerability of CKD-379

NCT05719155

Phase 1 Completed 32 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A study to compare the pharmacokinetics and safety/tolerability between CKD-379 tablet and D759, D745, D150 combination

Timeline

Start
2023-02-27
Primary completion
2023-03-23
Completion
2023-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-379 Unknown
Subject D150 Unknown
Subject D745 Unknown
Subject D759 Unknown